Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Stransky

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Bioinformatics (Oxford, England)|September 24, 2004
Analysis of array CGH data: from signal ratio to gain and loss of DNA regionsPhilippe Hupé, Nicolas Stransky, Jean-Paul Thiery, et al.
Nature Communications|September 11, 2014
The landscape of kinase fusions in cancerNicolas Stransky, Ethan Cerami, Stefanie Schalm, et al.
The Journal of Clinical Investigation|May 2, 2015
Targeting cancer with kinase inhibitorsStefan Gross, Rami Rahal, Nicolas Stransky, et al.
Genome Biology|October 23, 2019
Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methodsBrian J Haas, Alexander Dobin, Bo Li, et al.
Bioinformatics (Oxford, England)|July 21, 2004
Selecting biomedical data sources according to user preferencesSarah Cohen Boulakia, Séverine Lair, Nicolas Stransky, et al.
The Journal of Pathology|June 8, 2010
Frequent genomic structural alterations at HPV insertion sites in cervical carcinomaMartine Peter, Nicolas Stransky, Jérôme Couturier, et al.
Cancer Research|September 2, 2008
Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancerIsabelle Bernard-Pierrot, Nadège Gruel, Nicolas Stransky, et al.
NPJ Precision Oncology|July 31, 2025
Predicting ROS1 and ALK fusions in NSCLC from H&E slides with a two-step vision transformer approachEghbal Amidi, Mohammadreza Ramzanpour, Ming Chen, et al.
Journal of the National Cancer Institute|December 22, 2010
A novel epigenetic phenotype associated with the most aggressive pathway of bladder tumor progressionCéline Vallot, Nicolas Stransky, Isabelle Bernard-Pierrot, et al.
Plos One|June 14, 2011
Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancerAmit Dutt, Alex H Ramos, Peter S Hammerman, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Bioinformatics (Oxford, England)|September 24, 2004
Analysis of array CGH data: from signal ratio to gain and loss of DNA regionsPhilippe Hupé, Nicolas Stransky, Jean-Paul Thiery, et al.
Nature Communications|September 11, 2014
The landscape of kinase fusions in cancerNicolas Stransky, Ethan Cerami, Stefanie Schalm, et al.
The Journal of Clinical Investigation|May 2, 2015
Targeting cancer with kinase inhibitorsStefan Gross, Rami Rahal, Nicolas Stransky, et al.
Genome Biology|October 23, 2019
Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methodsBrian J Haas, Alexander Dobin, Bo Li, et al.
Bioinformatics (Oxford, England)|July 21, 2004
Selecting biomedical data sources according to user preferencesSarah Cohen Boulakia, Séverine Lair, Nicolas Stransky, et al.
The Journal of Pathology|June 8, 2010
Frequent genomic structural alterations at HPV insertion sites in cervical carcinomaMartine Peter, Nicolas Stransky, Jérôme Couturier, et al.
Cancer Research|September 2, 2008
Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancerIsabelle Bernard-Pierrot, Nadège Gruel, Nicolas Stransky, et al.
NPJ Precision Oncology|July 31, 2025
Predicting ROS1 and ALK fusions in NSCLC from H&E slides with a two-step vision transformer approachEghbal Amidi, Mohammadreza Ramzanpour, Ming Chen, et al.
Journal of the National Cancer Institute|December 22, 2010
A novel epigenetic phenotype associated with the most aggressive pathway of bladder tumor progressionCéline Vallot, Nicolas Stransky, Isabelle Bernard-Pierrot, et al.
Plos One|June 14, 2011
Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancerAmit Dutt, Alex H Ramos, Peter S Hammerman, et al.
Pageof 5